{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:49Z","timestamp":1787241949718,"version":"build-2736575974"},"reference-count":59,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004212","name":"Paivikki and Sakari Sohlberg Fundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004212","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003756","name":"Biomedicum Helsinki Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005744","name":"Lastentautien Tutkimuss\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005744","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002276","name":"Pediatric Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010711","name":"Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010128","name":"Lasten Sy\u00f6p\u00e4s\u00e4\u00e4ti\u00f6 V\u00e4reen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ajpath.2026.05.006","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:22:45Z","timestamp":1781104965000},"page":"1872-1890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Macrophage Polarization and Spatial Architecture Characterize the Tumor Immune Microenvironment and Prognosis in Hepatoblastoma"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9935-8816","authenticated-orcid":false,"given":"Ville J.","family":"V\u00e4yrynen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Eloranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Talka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7956-9043","authenticated-orcid":false,"given":"Antti","family":"Tuhkala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouko","family":"Lohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Varjosalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5271-2366","authenticated-orcid":false,"given":"Antti","family":"Kyr\u00f6nlahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1922-9732","authenticated-orcid":false,"given":"Sirpa","family":"Jalkanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3250-7653","authenticated-orcid":false,"given":"Maija","family":"Hollm\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9869-5706","authenticated-orcid":false,"given":"Marjut","family":"Pihlajoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Heikinheimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2026.05.006_bib1","doi-asserted-by":"crossref","first-page":"E555","DOI":"10.1002\/ijc.27351","article-title":"Hepatoblastoma in the Nordic countries","volume":"131","author":"de Fine Licht","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ajpath.2026.05.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.sempedsurg.2019.150856","article-title":"Surgical management of locally-advanced and metastatic hepatoblastoma","volume":"28","author":"Lake","year":"2019","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.ajpath.2026.05.006_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.sempedsurg.2016.09.002","article-title":"Malignant tumors of the liver in children","volume":"25","author":"Aronson","year":"2016","journal-title":"Semin Pediatr Surg"},{"key":"10.1016\/j.ajpath.2026.05.006_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.soc.2020.11.006","article-title":"Liver tumors in pediatric patients","volume":"30","author":"Meyers","year":"2021","journal-title":"Surg Oncol Clin N Am"},{"key":"10.1016\/j.ajpath.2026.05.006_bib5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.15252\/emmm.201707814","article-title":"Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma","volume":"9","author":"Crippa","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ajpath.2026.05.006_bib6","article-title":"Genotypic characteristics of hepatoblastoma as detected by next generation sequencing and their correlation with clinical efficacy","volume":"11","author":"Hu","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib7","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1038\/s41598-021-82542-4","article-title":"MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma","volume":"11","author":"Woodfield","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2026.05.006_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/cancers15020467","article-title":"Outcomes of patients treated for hepatoblastoma with low alpha-fetoprotein and\/or small cell undifferentiated histology: a report from the Children's Hepatic Tumors International Collaboration (CHIC)","volume":"15","author":"Trobaugh-Lotrario","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2026.05.006_bib9","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/cancers11091387","article-title":"Prognostic factors for event-free survival in pediatric patients with hepatoblastoma based on the 2017 PRETEXT and CHIC-HS systems","volume":"11","author":"Yoon","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2026.05.006_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejca.2015.09.023","article-title":"The Children's Hepatic tumors International Collaboration (CHIC): novel global rare tumor database yields new prognostic factors in hepatoblastoma and becomes a research model","volume":"52","author":"Czauderna","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ajpath.2026.05.006_bib11","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/petr.12144","article-title":"Surgical treatment of primary liver tumors in children: outcomes analysis of resection and transplantation in the SEER database","volume":"17","author":"McAteer","year":"2013","journal-title":"Pediatr Transplant"},{"key":"10.1016\/j.ajpath.2026.05.006_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/cncr.33848","article-title":"The cumulative incidence of cisplatin-induced hearing loss in young children is higher and develops at an early stage during therapy compared with older children based on 2052 audiological assessments","volume":"128","author":"Meijer","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.ajpath.2026.05.006_bib13","first-page":"1860","article-title":"Elevated mutational age in blood of children treated for cancer contributes to therapy-related myeloid neoplasms","volume":"12","author":"Bertrums","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2026.05.006_bib14","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib15","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1056\/NEJMoa0810613","article-title":"Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma","volume":"361","author":"Perilongo","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2026.05.006_bib16","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/cam4.4537","article-title":"IL-34 in hepatoblastoma cells potentially promote tumor progression via autocrine and paracrine mechanisms","volume":"11","author":"Irie","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.ajpath.2026.05.006_bib17","doi-asserted-by":"crossref","first-page":"4878","DOI":"10.1038\/s41467-022-32473-z","article-title":"Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids","volume":"13","author":"Song","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2026.05.006_bib18","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1158\/2159-8290.CD-20-1809","article-title":"Integrated genomic analysis identifies driver genes and cisplatin-resistant progenitor phenotype in pediatric liver cancer","volume":"11","author":"Hirsch","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2026.05.006_bib19","article-title":"Intratumoral erythroblastic islands restrain anti-tumor immunity in hepatoblastoma","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajpath.2026.05.006_bib20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jhep.2025.01.031","article-title":"Multiomic analysis uncovers a continuous spectrum of differentiation and Wnt-MDK-driven immune evasion in hepatoblastoma","volume":"83","author":"M\u00fcnter","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00262-025-04164-3","article-title":"High-plex imaging of hepatoblastoma and adjacent liver in pediatric patients reveals a predominant myeloid infiltrate expressing immune-checkpoints","volume":"74","author":"Krijgsman","year":"2025","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ajpath.2026.05.006_bib22","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/1078-0432.CCR-20-3141","article-title":"Composition, spatial characteristics, and prognostic significance of myeloid cell infiltration in pancreatic cancer","volume":"27","author":"V\u00e4yrynen","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.05.006_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70304","article-title":"Macrophages: subtypes, distribution, polarization, immunomodulatory functions, and therapeutics","volume":"6","author":"Peng","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.ajpath.2026.05.006_bib24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0531-5565(98)00058-8","article-title":"CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging","volume":"34","author":"Rea","year":"1999","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib25","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/cancers13153841","article-title":"Expression of HLA-DR in cytotoxic T lymphocytes: a validated predictive biomarker and a potential therapeutic strategy in breast cancer","volume":"13","author":"Saraiva","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ajpath.2026.05.006_bib26","doi-asserted-by":"crossref","first-page":"523","DOI":"10.4049\/jimmunol.2100011","article-title":"HLA-DR marks recently divided antigen-specific effector CD4 T cells in active tuberculosis patients","volume":"207","author":"Tippalagama","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib27","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1097\/HEP.0000000000000600","article-title":"Spatial proximity of tumor-immune interactions predicts patient outcome in hepatocellular carcinoma","volume":"79","author":"Maestri","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2026.05.006_bib28","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1074\/mcp.TIR118.000900","article-title":"Online parallel accumulation\u2013serial fragmentation (PASEF) with a novel trapped ion mobility mass spectrometer","volume":"17","author":"Meier","year":"2018","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ajpath.2026.05.006_bib29","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41592-020-00998-0","article-title":"diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition","volume":"17","author":"Meier","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2026.05.006_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41592-019-0638-x","article-title":"DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput","volume":"17","author":"Demichev","year":"2020","journal-title":"Nat Methods"},{"key":"10.1016\/j.ajpath.2026.05.006_bib31","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1038\/s41467-022-31492-0","article-title":"dia-PASEF data analysis using FragPipe and DIA-NN for deep proteomics of low sample amounts","volume":"13","author":"Demichev","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2026.05.006_bib32","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2443.2007.01065.x","article-title":"Oxidative stress induces p53-dependent apoptosis in hepatoblastoma cell through its nuclear translocation","volume":"12","author":"Yamamoto","year":"2007","journal-title":"Genes Cells"},{"key":"10.1016\/j.ajpath.2026.05.006_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00795-022-00323-y","article-title":"M-CSFR expression in the embryonal component of hepatoblastoma and cell-to-cell interaction between macrophages and hepatoblastoma","volume":"55","author":"Li","year":"2022","journal-title":"Med Mol Morphol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib34","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1158\/1078-0432.CCR-14-1236","article-title":"Clever-1\/stabilin-1 controls cancer growth and metastasis","volume":"20","author":"Karikoski","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.05.006_bib35","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1038\/s41467-019-11788-4","article-title":"Macrophage spatial heterogeneity in gastric cancer defined by multiplex immunohistochemistry","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.ajpath.2026.05.006_bib36","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100070","article-title":"Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma","volume":"1","author":"Abou-Alfa","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.ajpath.2026.05.006_bib37","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cell.2020.08.040","article-title":"Onco-fetal reprogramming of endothelial cells drives immunosuppressive macrophages in hepatocellular carcinoma","volume":"183","author":"Sharma","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2026.05.006_bib38","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.cell.2019.10.003","article-title":"Landscape and dynamics of single immune cells in hepatocellular carcinoma","volume":"179","author":"Zhang","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.ajpath.2026.05.006_bib39","first-page":"1","article-title":"Checkpoint immunotherapy in pediatrics: here, gone, and back again","author":"Long","year":"2022","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.ajpath.2026.05.006_bib40","article-title":"Single-cell profiles delineate immune cell remodeling and enhanced tumor-fibroblast interaction of hepatoblastoma after chemotherapy","volume":"6","author":"Chen","year":"2025","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajpath.2026.05.006_bib41","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1158\/2767-9764.CRC-24-0311","article-title":"Chemotherapy enriches for proinflammatory macrophage phenotypes that support cancer stem-like cells and disease progression in ovarian cancer","volume":"4","author":"Cruz","year":"2024","journal-title":"Cancer Res Commun"},{"key":"10.1016\/j.ajpath.2026.05.006_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.644608","article-title":"Plinabulin, a distinct microtubule-targeting chemotherapy, promotes M1-like macrophage polarization and anti-tumor immunity","volume":"11","author":"Natoli","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib43","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3390\/biomedicines10081822","article-title":"How chemotherapy affects the tumor immune microenvironment: a narrative review","volume":"10","author":"Merlano","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ajpath.2026.05.006_bib44","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1002\/1878-0261.12851","article-title":"Targeting immunogenic cell death in cancer","volume":"14","author":"Ahmed","year":"2020","journal-title":"Mol Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib45","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1158\/1078-0432.CCR-18-3016","article-title":"Immunotherapeutic blockade of macrophage Clever-1 reactivates the CD8+ T-cell response against immunosuppressive tumors","volume":"25","author":"Viitala","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ajpath.2026.05.006_bib46","article-title":"Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: the phase I\/II first-in-human MATINS trial","volume":"4","author":"Rannikko","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.ajpath.2026.05.006_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abo5570","article-title":"Immunogenomic cancer evolution: a framework to understand cancer immunosuppression","volume":"10","author":"Kumagai","year":"2025","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic [beta]-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.ajpath.2026.05.006_bib49","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ajpath.2026.05.006_bib50","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1158\/2159-8290.CD-19-0074","article-title":"-Catenin activation promotes immune escape and resistance to anti-PD-1 therapy in hepatocellular carcinoma","volume":"9","author":"Ruiz de Galarreta","year":"2019","journal-title":"Cancer Discov"},{"key":"10.1016\/j.ajpath.2026.05.006_bib51","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.jhep.2022.03.015","article-title":"Unique molecular characteristics of NAFLD-associated liver cancer accentuate [beta]-catenin\/TNFRSF19-mediated immune evasion","volume":"77","author":"Wong","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib52","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.3389\/fonc.2019.01512","article-title":"Ch\u2019ng ES: Evaluating the polarization of tumor-associated macrophages into M1 and M2 phenotypes in human cancer tissue: technicalities and challenges in routine clinical practice","volume":"9","author":"Jayasingam","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib53","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1638102","article-title":"M1 macrophages \u2013 unexpected contribution to tumor progression","volume":"16","author":"Kovaleva","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib54","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.1245\/s10434-023-13384-9","article-title":"Prognostic impact of tumor-associated macrophage-related markers in patients with adenocarcinoma of the lung","volume":"30","author":"Shikanai","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib55","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1245\/s10434-016-5244-x","article-title":"The prognostic significance of pSTAT1 and CD163 expressions in surgically resected stage 1 pulmonary squamous cell carcinomas","volume":"23","author":"Lin","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib56","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.174.8.4880","article-title":"STAT1 signaling regulates tumor-associated macrophage-mediated T cell deletion","volume":"174","author":"Kusmartsev","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2026.05.006_bib57","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/med.21599","article-title":"Inducible nitric oxide synthase: regulation, structure, and inhibition","volume":"40","author":"Cinelli","year":"2020","journal-title":"Med Res Rev"},{"key":"10.1016\/j.ajpath.2026.05.006_bib58","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3390\/biom13010119","article-title":"The role of JAK\/STAT pathway in fibrotic diseases: molecular and cellular mechanisms","volume":"13","author":"Liu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ajpath.2026.05.006_bib59","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10555-021-09957-3","article-title":"The role of tumor heterogeneity in immune-tumor interactions","volume":"40","author":"Knoche","year":"2021","journal-title":"Cancer Metastasis Rev"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026001641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944026001641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T10:25:52Z","timestamp":1787221552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944026001641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":59,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0002944026001641"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.05.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Macrophage Polarization and Spatial Architecture Characterize the Tumor Immune Microenvironment and Prognosis in Hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2026.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Society for Investigative Pathology.","name":"copyright","label":"Copyright"}]}}